Literature DB >> 25186973

Interstitial lung disease with multiple microgranulomas in chronic granulomatous disease.

Toshinao Kawai1, Nobuyuki Watanabe, Midori Yokoyama, Yumiko Nakazawa, Fumihiro Goto, Toru Uchiyama, Masataka Higuchi, Takanobu Maekawa, Eiichiro Tamura, Satoshi Nagasaka, Masayuki Hojo, Masafumi Onodera.   

Abstract

BACKGROUND: Chronic granulomatous disease (CGD) is a primary immunodeficiency disease that is characterized by susceptibility to bacterial and fungal infections. CGD patients also suffer from immune regulatory disorders, such as CGD-associated bowel inflammation with granuloma, which could be caused by excessive inflammation without demonstrable infection.
PURPOSE: We investigated the clinical manifestation of interstitial lung disease (ILD) resulting from excessive inflammation in X-linked CGD patients.
METHODS: Pulmonary CT images and testing of serum KL-6 levels were performed to assess ILD in the patients. For this study, patients with pulmonary lesions due to demonstrable infections were excluded from among ILD patients.
RESULTS: Among 33 CGD patients, four developed ILD; they had increased reticulo-nodular opacities on CT images and elevated serum KL-6 levels. Histopathological examinations revealed multiple homogeneous microgranulomas in the lesions of inflammatory cell infiltration. Mononuclear cells obtained from their pulmonary lesions produced higher amounts of inflammatory cytokines than the peripheral blood mononuclear cells of CGD patients, suggesting that the only infiltrating cells in the pulmonary lesions were activated and produced large amounts of inflammatory cytokines in ILD patients. Interestingly, an anti-inflammatory drug, such as a corticosteroid or thalidomide, but not anti-bacterial or anti-fungal drugs, improved CT image findings and reduced their KL-6 levels.
CONCLUSIONS: CGD patients' daily exposures to inhaled antigens may induce excessive reactions with the production of inflammatory cytokines leading to the development of ILD with multiple microgranulomas, which could be due to an inadequate production of reactive oxygen species in CGD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25186973     DOI: 10.1007/s10875-014-0089-1

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  31 in total

Review 1.  Chronic granulomatous disease.

Authors:  Steven M Holland
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 8.667

2.  The macrophage beta-glucan receptor mediates arachidonate release induced by zymosan: essential role for Src family kinases.

Authors:  Sandra Olsson; Roger Sundler
Journal:  Mol Immunol       Date:  2006-11-03       Impact factor: 4.407

3.  Osteomyelitis due to trimethoprim/sulfamethoxazole-resistant Edwardsiella tarda infection in a patient with X-linked chronic granulomatous disease.

Authors:  T Kawai; H Kusakabe; A Seki; S Kobayashi; M Onodera
Journal:  Infection       Date:  2011-01-19       Impact factor: 3.553

4.  PPARγ activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous disease.

Authors:  Ruby Fernandez-Boyanapalli; S Courtney Frasch; David W H Riches; R William Vandivier; Peter M Henson; Donna L Bratton
Journal:  Blood       Date:  2010-08-06       Impact factor: 22.113

5.  Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease.

Authors:  Frank L van de Veerdonk; Sanne P Smeekens; Leo A B Joosten; Bart Jan Kullberg; Charles A Dinarello; Jos W M van der Meer; Mihai G Netea
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

Review 6.  Where asthma and hypersensitivity pneumonitis meet and differ: noneosinophilic severe asthma.

Authors:  Pieter Bogaert; Kurt G Tournoy; Thomas Naessens; Johan Grooten
Journal:  Am J Pathol       Date:  2008-12-12       Impact factor: 4.307

7.  Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica.

Authors:  Catherine Dostert; Virginie Pétrilli; Robin Van Bruggen; Chad Steele; Brooke T Mossman; Jürg Tschopp
Journal:  Science       Date:  2008-04-10       Impact factor: 47.728

Review 8.  Aspergillus-associated hypersensitivity respiratory disorders.

Authors:  Ashok Shah
Journal:  Indian J Chest Dis Allied Sci       Date:  2008 Jan-Mar

Review 9.  Thalidomide for treatment of multiple myeloma: 10 years later.

Authors:  Antonio Palumbo; Thierry Facon; Pieter Sonneveld; Joan Bladè; Massimo Offidani; Francesca Gay; Philippe Moreau; Anders Waage; Andrew Spencer; Heinz Ludwig; Mario Boccadoro; Jean-Luc Harousseau
Journal:  Blood       Date:  2008-02-01       Impact factor: 22.113

10.  1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.

Authors:  Laurence Senn; James Owen Robinson; Sabine Schmidt; Marlies Knaup; Nobuo Asahi; Shinji Satomura; Shuuji Matsuura; Bertrand Duvoisin; Jacques Bille; Thierry Calandra; Oscar Marchetti
Journal:  Clin Infect Dis       Date:  2008-03-15       Impact factor: 9.079

View more
  7 in total

1.  Severe Aspergillus Pneumonia and Pulmonary Artery Hypertension in a Child with Autosomal Recessive Chronic Granulomatous Disease and Selective IgA Deficiency.

Authors:  Ankur K Jindal; Amit Rawat; Deepti Suri; Madhubala Sharma; Jitendra K Shandilya; Shubham Goel; Kushaljit S Sodhi; Surjit Singh
Journal:  J Clin Immunol       Date:  2017-03-24       Impact factor: 8.317

2.  Pulmonary Disease Burden in Primary Immune Deficiency Disorders: Data from USIDNET Registry.

Authors:  Meera Patrawala; Ying Cui; Limin Peng; Ramsay L Fuleihan; Elizabeth K Garabedian; Kiran Patel; Lokesh Guglani
Journal:  J Clin Immunol       Date:  2020-01-09       Impact factor: 8.317

3.  Diagnosis of Interstitial Lung Disease Caused by Possible Hypersensitivity Pneumonitis in a Child: Think CGD.

Authors:  Saliha Esenboga; Nagehan Emiralioglu; Deniz Cagdas; Baran Erman; Martin De Boer; Berna Oguz; Nural Kiper; İlhan Tezcan
Journal:  J Clin Immunol       Date:  2017-02-21       Impact factor: 8.317

4.  Macrophage NOX2 NADPH oxidase maintains alveolar homeostasis in mice.

Authors:  Sourav Bhattacharya; Rachel A Idol; Wei Yang; Jorge David Rojas Márquez; Yanan Li; Guangming Huang; Wandy L Beatty; Jeffrey J Atkinson; John H Brumell; Juhi Bagaitkar; Jeffrey A Magee; Mary C Dinauer
Journal:  Blood       Date:  2022-05-12       Impact factor: 25.476

5.  HMGB1 induces lung fibroblast to myofibroblast differentiation through NF‑κB‑mediated TGF‑β1 release.

Authors:  Qiong Wang; Jun Wang; Junfang Wang; Shanchao Hong; Feifei Han; Jingyu Chen; Guoqian Chen
Journal:  Mol Med Rep       Date:  2017-03-23       Impact factor: 2.952

6.  Etiologic spectrum of interstitial lung diseases in Chinese children older than 2 years of age.

Authors:  Xiaolei Tang; Huimin Li; Hui Liu; Hui Xu; Haiming Yang; Jinrong Liu; Shunying Zhao
Journal:  Orphanet J Rare Dis       Date:  2020-01-22       Impact factor: 4.123

7.  Mimicking hypersensitivity pneumonitis as an uncommon initial presentation of chronic granulomatous disease in children.

Authors:  Hui Liu; Jinrong Liu; Huimin Li; Yun Peng; Shunying Zhao
Journal:  Orphanet J Rare Dis       Date:  2017-10-26       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.